Sansure Biotech Inc (688289) — Financial Flexibility Index
Sansure Biotech Inc (688289) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥122.80 Million (operating CF CN¥59.72 Million minus capex CN¥63.08 Million) represents 0% of total liabilities (CN¥2.24 Billion). Also explore 688289 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sansure Biotech Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Sansure Biotech Inc across 8 annual periods. Check asset resilience ratio of Sansure Biotech Inc to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Sansure Biotech Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Sansure Biotech Inc. For the full company profile including market capitalisation, see 688289 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.55x | CN¥695.55 Million | CN¥274.45 Million | CN¥1.26 Billion | ▲ +12.9% |
| 2023 | 0.49x | CN¥504.17 Million | CN¥112.82 Million | CN¥1.03 Billion | ▼ -73.9% |
| 2022 | 1.88x | CN¥3.12 Billion | CN¥2.56 Billion | CN¥1.66 Billion | ▼ -40.8% |
| 2021 | 3.17x | CN¥2.25 Billion | CN¥1.88 Billion | CN¥709.03 Million | ▼ -18.2% |
| 2020 | 3.88x | CN¥2.75 Billion | CN¥2.64 Billion | CN¥708.95 Million | ▲ +483.2% |
| 2019 | 0.67x | CN¥56.55 Million | CN¥22.41 Million | CN¥84.99 Million | ▲ +141.2% |
| 2018 | 0.28x | CN¥42.97 Million | CN¥10.07 Million | CN¥155.76 Million | ▲ +226.3% |
| 2017 | -0.22x | CN¥-40.76 Million | CN¥-61.44 Million | CN¥186.62 Million | — |